ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2436

Characterizing Spatial Organization of Immune Infiltrates in Rheumatoid Arthritis Synovia Using Spatial Transcriptomic Analysis

Roopa Madhu1, Kartik Bhamidipati1, Anna Helena Jonsson1, Fan Zhang2, Lucy MacDonald3, Youngmi Kim4, Yi Cui4, STARS BWH1, Accelerating Medicines Partnership Program RA SLE Network5, Mariola Kurowska-Stolarska3, Stefano Alvernini6, Ellen Gravallese7, Michael Brenner7, Soumya Raychaudhuri1, Kevin Wei7 and ilya Korsunsky1, 1Brigham and Women's Hospital, Boston, MA, 2University of Colorado, Aurora, CO, 3Research into Inflammatory Arthritis Centre Versus Arthritis (RACE), University of Glasgow, Glasgow, United Kingdom, 4Nanostring, Seattle, WA, 5Cedars-Sinai Medical Center, Los Angeles, CA, 6Division of Rheumatology, Università Cattolica del Sacro Cuore, Rome, Italy, 7Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2023

Keywords: Imaging, rheumatoid arthritis, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: Abstracts: RA – Etiology & Pathogenesis

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by immune infiltration of the synovial tissue lining joints. RA is clinically heterogenous, with patients having varied responses to therapies, likely reflecting distinct pathogenic mechanisms. To begin to define the heterogeneity in RA, a recent study showed that the fractional abundances of 5 cell types can help predict treatment response in some subsets of RA (1). With the goal of better understanding the spatial organization of cells in RA synovial tissues and mapping cell-cell interactions, we sought to take a key next step in defining RA heterogeneity and its relation to treatment response

Methods:
Spatial transcriptomic profiling

We used CosMx Spatial Molecular Imager to measure the RNA expression levels of 960 genes in 10 paraffin-embedded inflamed synovial tissue samples.

Cell segmentation and annotation

We developed a segmentation pipeline to map transcripts to cells, and then classified each cell into one of 10 major cell types. We used the single-cell RNA seq synovial atlas to map these cells further into fine-grained cell-states.

Niche detection and characterization

We performed spatial tissue segmentation to identify contiguous and transcriptionally homogeneous sections of the tissue called “niches”. We split tissues into tiles and performed spatial clustering of the tiles to detect niches.

Results:
1. Identification of major and fine-grain cell types in situ. We segmented and labeled 333,966 high quality cells across 10 RA synovial tissue samples. We identified 10 major cell lineages (Figure 1A-B), including 2 absent in single-cell RNA-seq studies: mast cells and neutrophils. We subclassified cells into 54 subtypes and activation states based on prior definitions from the AMP single-cell RNA-seq atlas of inflamed synovium (1). We detected 2 cell states of mast cells (resting and activated) and 3 cell states of neutrophils (resting, activated, and proliferating) based on key gene expression markers.

2. Quantification of anatomic niches. We mapped annotated cells into tissue space, where they organized into anatomic structures: vasculature (endothelial and mural cells), lining (lining fibroblasts and MERTK+ macrophages), and immune aggregates (T, B, and plasma cells) (Figure 2A-C). We quantified the boundaries of these niches and identified all niches in most samples. We next quantified the relative composition of niches within and across donors and observed significant heterogeneity of niches within samples (Figure 2D-F).

3. Validation with independent cohort. We validated our spatial organization results in an independent inflamed synovial tissue cohort from 3 patients with treatment naïve RA. Using our pipeline, we found similar proportions of cell types and organization of cells into the canonical niches defined in our spatial atlas (Figure 3A, B).

Conclusion: We established a draft spatial atlas of RA synovium and provided spatial context for 54 cell types, subtypes, and activation states observed in dissociated tissue assays. This atlas will serve as a reference to map the cellular organization in different cohorts as demonstrated and eventually enable us to compare the effects of different therapeutics on the RA tissue.

Supporting image 1

Identification of major cell types in situ (A) Cells projected in UMAP space, colored by their major cell type. (B) Heatmap of gene log fold-changes for each of the major cell types. Top 3 marker genes for each cluster are annotated on the x-axis.

Supporting image 2

Identification of anatomical niches (A-C) Cells in tissue space in active RA synovium. Each panel shows an FOV from a tissue sample. Red ovals in each FOV highlight an anatomical niche (A) immune aggregate, (B) vascular niche, (C) lining. (D-F) Niches in space: each panel shows detected niches in the FOVs shown in A-C. FOV: Field of view

Supporting image 3

Anatomical niches across cohorts (A) Cells in tissue space in active RA synovium organized into an immune aggregate (B) Cells in tissue space in treatment naïve RA synovium. Red oval highlights the immune aggregate niche.


Disclosures: R. Madhu: None; K. Bhamidipati: None; A. Jonsson: None; F. Zhang: None; L. MacDonald: None; Y. Kim: NANOSTRING, 3; Y. Cui: NANOSTRING, 3; S. BWH: Mestag Therapeutics, 2; A. RA SLE Network: None; M. Kurowska-Stolarska: None; S. Alvernini: None; E. Gravallese: Associate Editor, New England Journal of Medicine, 3, Co-editor of the textbook Rheumatology, 9, UptoDate, 9; M. Brenner: 4FO Ventures, 2, GlaxoSmithKlein(GSK), 2, Mestag Therapeutics, 2, 11, Third Rock Ventures, 2; S. Raychaudhuri: AbbVie, 6, Janssen, 1, Mestag, Inc, 2, 8, Pfizer, 1, Sanofi, 1, Sonoma, 1, 8; K. Wei: 10X Genomics, 5, capital one, 6, Gilead sciences, 5, horizon therapeutics, 6, Mestag, 2; i. Korsunsky: Mestag Therapeutics, 2.

To cite this abstract in AMA style:

Madhu R, Bhamidipati K, Jonsson A, Zhang F, MacDonald L, Kim Y, Cui Y, BWH S, RA SLE Network A, Kurowska-Stolarska M, Alvernini S, Gravallese E, Brenner M, Raychaudhuri S, Wei K, Korsunsky i. Characterizing Spatial Organization of Immune Infiltrates in Rheumatoid Arthritis Synovia Using Spatial Transcriptomic Analysis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/characterizing-spatial-organization-of-immune-infiltrates-in-rheumatoid-arthritis-synovia-using-spatial-transcriptomic-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterizing-spatial-organization-of-immune-infiltrates-in-rheumatoid-arthritis-synovia-using-spatial-transcriptomic-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology